Luz Jubierre
Overview
Explore the profile of Luz Jubierre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walsh R, Crabtree G, Kalpana K, Jubierre L, Koo S, Ciceri G, et al.
bioRxiv
. 2024 Dec;
PMID: 39651135
Disruption of parvalbumin positive (PVALB+) cortical interneurons is implicated in the pathogenesis of schizophrenia. However, how these defects emerge during brain development remains poorly understood. The protracted maturation of these...
2.
Jimenez C, Antonelli R, Masanas M, Soriano A, Devis-Jauregui L, Camacho J, et al.
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638328
Neuroblastoma is a pediatric tumor of the peripheral nervous system that accounts for up to ~15% of all cancer-related deaths in children. Recently, it has become evident that epigenetic deregulation...
3.
Qadeer Z, Valle-Garcia D, Hasson D, Sun Z, Cook A, Nguyen C, et al.
Cancer Cell
. 2019 Oct;
36(5):512-527.e9.
PMID: 31631027
ATRX alterations occur at high frequency in neuroblastoma of adolescents and young adults. Particularly intriguing are the large N-terminal deletions of ATRX (Alpha Thalassemia/Mental Retardation, X-linked) that generate in-frame fusion...
4.
Jubierre L, Jimenez C, Rovira E, Soriano A, Sabado C, Gros L, et al.
Exp Mol Med
. 2018 Apr;
50(4):1-12.
PMID: 29700278
Approximately 15,000 new cases of pediatric cancer are diagnosed yearly in Europe, with 8-10% corresponding to neuroblastoma, a rare disease with an incidence of 8-9 cases per million children <15...
5.
Feliciano A, Garcia-Mayea Y, Jubierre L, Mir C, Hummel M, Castellvi J, et al.
Cell Death Dis
. 2017 Oct;
8(10):e3141.
PMID: 29072692
Lung cancer is one of the most aggressive tumours with very low life expectancy. Altered microRNA expression is found in human tumours because it is involved in tumour growth, progression...
6.
Segura M, Jubierre L, Li S, Soriano A, Koetz L, Gaziel-Sovran A, et al.
Oncotarget
. 2017 Apr;
8(16):26298-26311.
PMID: 28412746
MicroRNAs (miRNAs) are a class of endogenous non-coding small RNAs that post-transcriptionally control the translation and stability of target mRNAs in a sequence-dependent manner. MiRNAs are essential for key cellular...
7.
Soriano A, Paris-Coderch L, Jubierre L, Martinez A, Zhou X, Piskareva O, et al.
Oncotarget
. 2016 Jan;
7(8):9271-87.
PMID: 26824183
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or function, activating the DNA...
8.
Almazan-Moga A, Roma J, Molist C, Vidal I, Jubierre L, Soriano A, et al.
Cytometry A
. 2014 Aug;
85(12):1020-9.
PMID: 25155056
Rhabdomyosarcoma (RMS) is the most common type of soft tissue sarcoma in children. Circulating tumor cells in peripheral blood or disseminated to bone marrow, a concept commonly referred to as...
9.
Segura M, Fontanals-Cirera B, Gaziel-Sovran A, Guijarro M, Hanniford D, Zhang G, et al.
Cancer Res
. 2013 Aug;
73(20):6264-76.
PMID: 23950209
Metastatic melanoma remains a mostly incurable disease. Although newly approved targeted therapies are efficacious in a subset of patients, resistance and relapse rapidly ensue. Alternative therapeutic strategies to manipulate epigenetic...
10.
Soriano A, Jubierre L, Almazan-Moga A, Molist C, Roma J, Sanchez de Toledo J, et al.
Pharmacol Res
. 2013 Mar;
75:3-14.
PMID: 23537752
The survival rate of cancer patients has increased considerably in the last 20 years owing to significant efforts made in prevention, early detection protocols, combined chemotherapy regimens, targeted therapies, refined...